Immunohistochemistry-based studies on tumour-infiltrating lymphocyte densities have revealed CD3+ and CD8+ T-cell density-based immune cell score (ICS) having significant prognostic value not only in the primary CRC tumour [16] but also in the liver and pulmonary metastases [17, 18]. This evidence concerns the gene CD8A and colorectal carcinoma.